Calr plus Myelofibrosis/BCR-ABL Chronic Myeloid Leukemia Overlap Syndrome Treated with Asciminib

被引：1

作者：

Saal, Talia M. ^{[1
]}

Pellegrino, Christine ^{[2
]}

Ahmed, Tauseef ^{[2
]}

Seiter, Karen ^{[3
]}

Liu, Delong ^{[2
]}

Steinberg, Amir ^{[2
]}

机构：

[1] New York Med Coll, Valhalla, NY 10595 USA

[2] Westchester Med Ctr, Valhalla, NY USA

[3] Westchester Med Ctr, Larchmont, NY USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-184820

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[31] The role of serial BCR-ABL transcript monitoring in predicting the emergence of BCR-ABL kinase mutations in imatinib-treated patients with chronic myeloid leukemia [J].

Wang, LH ;

Knight, K ;

Lucas, C ;

Clark, RE .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2006, 91 (02) :235-239

[32] Molecular breakpoint of BCR-ABL in chronic myeloid leukemia and imatinib response [J].

不详 .

PHARMACOGENOMICS, 2010, 11 (09) :1202-1203

[33] Chronic myeloid leukemia with p210 BCR-ABL and monocytosis [J].

Dass, Jasmita ;

Jain, Sonal ;

Tyagi, Seema ;

Sazawal, Sudha .

LEUKEMIA & LYMPHOMA, 2011, 52 (07) :1380-1381

[34] Characteristics of BCR-ABL gene variants in patients of chronic myeloid leukemia [J].

Amin, Huma ;

Ahmed, Suhaib .

OPEN MEDICINE, 2021, 16 (01) :904-912

[35] Identification of natural inhibitors of Bcr-Abl for the treatment of chronic myeloid leukemia [J].

Parcha, Phanikrishna ;

Sarvagalla, Sailu ;

Madhuri, Bindu ;

Pajaniradje, Sankar ;

Baskaran, Vinitha ;

Coumar, Mohane Selvaraj ;

Rajasekaran, Baskaran .

CHEMICAL BIOLOGY & DRUG DESIGN, 2017, 90 (04) :596-608

[36] Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia. [J].

Goldman, JM ;

Melo, JV .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1084-1086

[37] BCR-ABL independent gene mutations in patients with chronic myeloid leukemia [J].

Schmidt, M. ;

Rinke, J. ;

Schaefer, V. ;

Ziermann, J. ;

Eigendorff, E. ;

Hochhaus, A. ;

Ernst, T. .

ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 :210-210

[38] Imatinib mesylate, a selective inhibitor of BCR-ABL, in chronic myeloid leukemia [J].

Carella, Angelo Michele .

EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (03) :249-251

[39] Chronic myeloid leukemia, BCR-ABL1-positive with CALR and MPL mutations [J].

Klairmont, M. M. ;

Cheng, J. ;

Schwartzberg, L. ;

Ho, H. H. ;

Gradowski, J. F. .

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 (03) :E41-E42

[40] The role of Bcr-Abl in chronic myeloid leukemia and stem cell biology [J].

Witte, O .

SEMINARS IN HEMATOLOGY, 2001, 38 (03) :3-8

← 1 2 3 4 5 →